{
    "eid": "2-s2.0-85152305449",
    "title": "Discovery of Novel EGFR Inhibitor Targeting Wild-Type and Mutant Forms of EGFR: In Silico and In Vitro Study",
    "cover-date": "2023-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Analytical Chemistry",
            "@code": "1602",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Chemistry (miscellaneous)",
            "@code": "1601",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Physical and Theoretical Chemistry",
            "@code": "1606",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Organic Chemistry",
            "@code": "1605",
            "@abbrev": "CHEM"
        }
    ],
    "keywords": [
        "cytotoxicity",
        "drug screening",
        "EGFR-TK",
        "furopyridine",
        "molecular dynamics"
    ],
    "authors": [
        "Duangjai Todsaporn",
        "Alexander Zubenko",
        "Victor Kartsev",
        "Thitinan Aiebchun",
        "Panupong Mahalapbutr",
        "Anthi Petrou",
        "Athina Geronikaki",
        "Liudmila Divaeva",
        "Victoria Chekrisheva",
        "Ilkay Yildiz",
        "Kiattawee Choowongkomon",
        "Thanyada Rungrotmongkol"
    ],
    "citedby-count": 0,
    "ref-count": 60,
    "ref-list": [
        "Targeting drug resistance in EGFR with covalent inhibitors: A structure-based design approach",
        "Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: Comparative pharmacokinetics and drug\u2013drug interactions",
        "A comprehensive pathway map of epidermal growth factor receptor signaling",
        "Untangling the ErbB signalling network",
        "Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery",
        "Epidermal growth factor receptor-mediated cell motility: Phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement",
        "A family of proteins that inhibit signalling through tyrosine kinase receptors",
        "A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerization",
        "Osimertinib making a breakthrough in lung cancer targeted therapy",
        "Epidermal growth factor receptor (EGFR) in lung cancer: An overview and update",
        "Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway",
        "Epidermal growth factor receptor (EGFR) signaling in cancer",
        "Global cancer statistics, 2012",
        "The role of adjuvant monoclonal antibody therapy for breast cancer: Rationale and new studies",
        "Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder",
        "Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: An immunohistochemical and chromogenic in situ hybridization study",
        "Erlotinib in previously treated non\u2013small-cell lung cancer",
        "Cancer statistics, 2015",
        "Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer",
        "Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non\u2013small cell lung cancer: A randomized trial",
        "Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR",
        "Epidermal growth factor receptor (EGFR) signaling and covalent EGFR inhibition in lung cancer",
        "Drug discovery for a new generation of covalent drugs",
        "Drug\u2013target residence time and its implications for lead optimization",
        "Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib",
        "AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer",
        "Discovery of (R, E)-N-(7-Chloro-1-(1-[4-(dimethylamino) but-2-enoyl] azepan-3-yl)-1 H-benzo [d] imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers",
        "Novel mutant-selective EGFR kinase inhibitors against EGFR T790M",
        "Discovery of selective irreversible inhibitors for EGFR-T790M",
        "Discovery of n-((3 r, 4 r)-4-fluoro-1-(6-((3-methoxy-1-methyl-1 h-pyrazol-4-yl) amino)-9-methyl-9 h-purin-2-yl) pyrrolidine-3-yl) acrylamide (pf-06747775) through structure-based drug design: A high affinity irreversible inhibitor targeting oncogenic egfr mutants with selectivity over wild-type egfr",
        "Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models",
        "Synthesis and cytotoxicity of thieno [2, 3-b] pyridine and furo [2, 3-b] pyridine derivatives",
        "Design and synthesis of new imidazo [1, 2-a] pyridine and imidazo [1, 2-a] pyrazine derivatives with antiproliferative activity against melanoma cells",
        "Synthesis, characterization and cytotoxicity of new nicotinonitriles and their furo [2, 3-b] pyridine derivatives",
        "Polymorphic study and anti-inflammatory activity of a 3-cyano-2-pyridone based flexible model",
        "Identification of MK-944a: A second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitors",
        "Substituted furopyridinediones as novel inhibitors of a-glucosidase",
        "Structure\u2013activity relationships in human Toll-like receptor 8-active 2, 3-diamino-furo [2, 3-c] pyridines",
        "Structural Modification of Pyridoxal. Synthesis and Evaluation of Anti-Infective Activity of New 4-Chloro-and 4-Alkyl (dialkyl) aminomethyl-2-hetaryl (hetaroyl) furo[2, 3-c] pyridines",
        "Synthesis and evaluation of 2, 9-disubstituted 8-phenylthio/phenylsulfinyl-9H-purine as new EGFR inhibitors",
        "Computational and Synthetic approach with Biological Evaluation of Substituted Quinoline derivatives as small molecule L858R/T790M/C797S triple mutant EGFR inhibitors targeting resistance in Non-Small Cell Lung Cancer (NSCLC)",
        "Structure-based design of 5-methylpyrimidopyridone derivatives as new wild-type sparing inhibitors of the epidermal growth factor receptor triple mutant (EGFRL858R/T790M/C797S)",
        "Structural signature of the G719S-T790M double mutation in the EGFR kinase domain and its response to inhibitors",
        "Rational design of non-resistant targeted cancer therapies",
        "Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor",
        "Identification of natural flavonoids as novel EGFR inhibitors using DFT, molecular docking, and molecular dynamics",
        "Synthesis and evaluation of novel non-covalent binding quinazoline glycoside derivatives targeting the L858R and T790M variants of EGFR",
        "Discovery of novel 9-heterocyclyl substituted 9H-purines as L858R/T790M/C797S mutant EGFR tyrosine kinase inhibitors",
        "Structural and energetic basis for the molecular recognition of dual synthetic vs. natural inhibitors of EGFR/HER2",
        "Evaluation of the binding behavior of olmutinib (HM61713) with model transport protein: Insights from spectroscopic and molecular docking studies",
        "Investigation on the protein-binding properties of icotinib by spectroscopic and molecular modeling method",
        "CH7233163 overcomes osimertinib resistant EGFR-Del19/T790M/C797S mutation",
        "Insights into the aberrant activity of mutant EGFR kinase domain and drug recognition",
        "Routine microsecond molecular dynamics simulations with AMBER on GPUs",
        "Development and testing of a general amber force field",
        "ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB",
        "Comparison of simple potential functions for simulating liquid water",
        "Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes",
        "MMPBSA. py: An efficient program for end-state free energy calculations"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Novocherkassk",
            "@id": "60110484",
            "affilname": "North-Caucasian Zonal Research Veterinary Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60110484",
            "affiliation-country": "Russian Federation"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rostov-on-Don",
            "@id": "60025383",
            "affilname": "Southern Federal University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025383",
            "affiliation-country": "Russian Federation"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60021944",
            "affilname": "Kasetsart University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021944",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Thessaloniki",
            "@id": "60015331",
            "affilname": "Aristotle University of Thessaloniki",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015331",
            "affiliation-country": "Greece"
        },
        {
            "affiliation-city": "Ankara",
            "@id": "60012603",
            "affilname": "Ankara \u00dcniversitesi",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012603",
            "affiliation-country": "Turkey"
        },
        {
            "affiliation-city": "Moscow",
            "@id": "124314977",
            "affilname": "InterBioScreen",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124314977",
            "affiliation-country": "Russian Federation"
        }
    ],
    "funding": [
        "Fundamental Scientific Research of the State Academies of Sciences",
        "Chulalongkorn University",
        "Ministry of Science and Higher Education of the Russian Federation",
        "Faculty of Science, Chulalongkorn university",
        "Thailand Science Research and Innovation Fund"
    ]
}